BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21281948)

  • 1. Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer.
    Daly BD; Ebright MI; Walkey AJ; Fernando HC; Zaner KS; Morelli DM; Kachnic LA
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1392-7. PubMed ID: 21281948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.
    Paul S; Mirza F; Port JL; Lee PC; Stiles BM; Kansler AL; Altorki NK
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):48-58. PubMed ID: 21092990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
    Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
    Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
    Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of superior sulcus tumors: results and prognostic factors.
    Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
    Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis in patients with non-small cell lung cancer and satellite tumors.
    Kocaturk CI; Gunluoglu MZ; Cansever L; Dincer IS; Bedirhan MA
    Thorac Cardiovasc Surg; 2011 Sep; 59(6):360-3. PubMed ID: 21445825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes.
    Galvaing G; Tardy MM; Cassagnes L; Da Costa V; Chadeyras JB; Naamee A; Bailly P; Filaire E; Pereira B; Filaire M
    Ann Thorac Surg; 2014 May; 97(5):1708-13. PubMed ID: 24625436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
    Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer.
    Aokage K; Yoshida J; Ishii G; Enatsu S; Hishida T; Nishimura M; Nishiwaki Y; Nagai K
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1246-52, 1252.e1. PubMed ID: 19765741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.